Potential Role of Mepolizumab Therapy in Formation of NETs, EETs in EGPA Patients with EGPA receiving mepolizumab for 6 months saw an impact on neutrophil extracellular trap and eosinophilic extracellular trap formation.

#ACR25: In patients with the #EGPA type of #ANCA-associated vasculitis (#AAV) who receive #Mepolizumab treatment for 6 months, an impact on the formation of #NETs and #EETs has been observed.

Read more: https://bit.ly/4oLOO97

#RareDisease #Rheumatology #RheumSky #MedSky

#EverthingElonTouchesSinks
#EETS

EverythingElonTouchesSinks
#EETS

EverythingElonTouchesSinks
#EETS